Molecular Templates, Inc. (MTEM) SEC filings
MTEM SEC filings moved a median of -0.60% by the close. MTEM SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the MTEM overview →
37 measured MTEM SEC filing events.
Where these MTEM SEC filings landedvs 36 measured MTEM SEC filing reactions
| Middle 50% of MTEM SEC filing reactions | -6.49% to +5.54% |
|---|---|
| Median reaction (to close) | -0.60% |
| Measured reactions | 36 |
Point-in-time · zero look-ahead
Half of the 36 MTEM SEC filing events with a measured close landed between -6.49% and +5.54%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Molecular Templates, For: Apr 20 | SEC filing · Form 8-K | — | — | |
| Form 8-K Molecular Templates, For: Feb 20 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Molecular Templates, For: Dec 30 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K Molecular Templates, For: Dec 16 | SEC filing · Form 8-K | +16.00% | +6.67% | |
| Form 8-K Molecular Templates, For: Dec 04 | SEC filing · Form 8-K | +8.73% | +48.61% | |
| Form 8-K Molecular Templates, For: Nov 27 | SEC filing · Form 8-K | -1.96% | -10.62% | |
| Form DEFA14A Molecular Templates, | SEC filing · Form DEFA14A | +8.73% | +48.61% | |
| Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements | Press release | +0.00% | -2.63% | |
| Form 8-K Molecular Templates, For: Nov 25 | SEC filing · Form 8-K | -7.91% | -10.86% | |
| Form DEFA14A Molecular Templates, | SEC filing · Form DEFA14A | -7.91% | -10.86% | |
| Form NT 10-Q Molecular Templates, For: Sep 30 | SEC filing · Form NT | -9.20% | -12.67% | |
| Form DEF 14A Molecular Templates, For: Nov 26 | SEC filing · Form DEF | +0.18% | -9.98% | |
| Form PRE 14A Molecular Templates, For: Oct 17 | SEC filing · Form PRE | +7.84% | +9.49% | |
| Form 8-K Molecular Templates, For: Oct 11 | SEC filing · Form 8-K | -3.89% | +21.84% | |
| Form 8-K Molecular Templates, For: Oct 03 | SEC filing · Form 8-K | +0.00% | -2.04% | |
| Form 8-K Molecular Templates, For: Sep 27 | SEC filing · Form 8-K | +0.00% | +6.44% | |
| Form 10-Q Molecular Templates, For: Jun 30 | SEC filing · Form 10-Q | — | +6.43% | |
| Form 8-K Molecular Templates, For: Aug 14 | SEC filing · Form 8-K | — | +6.43% | |
| Form ARS Molecular Templates, For: Dec 31 | SEC filing · Form ARS | — | -6.49% | |
| Form DEF 14A Molecular Templates, For: Sep 27 | SEC filing · Form DEF | — | -6.49% | |
| Form DEFA14A Molecular Templates, | SEC filing · Form DEFA14A | — | -6.49% | |
| Form 8-K Molecular Templates, For: Jun 03 | SEC filing · Form 8-K | +1.68% | +12.50% | |
| Form 10-Q Molecular Templates, For: Mar 31 | SEC filing · Form 10-Q | — | +3.45% | |
| Form 8-K Molecular Templates, For: May 15 | SEC filing · Form 8-K | — | +3.45% | |
| Form EFFECT Molecular Templates, | SEC filing · Form EFFECT | — | -1.21% | |
| Form 10-K/A Molecular Templates, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.25% | |
| Form S-3 Molecular Templates, | SEC filing · Form S-3 | +0.00% | +5.25% | |
| Form 8-K Molecular Templates, For: Apr 11 | SEC filing · Form 8-K | +2.19% | -2.73% | |
| Form 10-K Molecular Templates, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.72% | |
| Form 8-K Molecular Templates, For: Mar 29 | SEC filing · Form 8-K | +0.00% | -3.72% | |
| Form S-8 Molecular Templates, | SEC filing · Form S-8 | +0.00% | -3.72% | |
| Form 8-K Molecular Templates, For: Mar 28 | SEC filing · Form 8-K | -4.04% | -17.65% | |
| Form 8-K Molecular Templates, For: Mar 15 | SEC filing · Form 8-K | -12.73% | -24.73% | |
| Form 8-K Molecular Templates, For: Jan 11 | SEC filing · Form 8-K | +0.00% | +3.00% | |
| Form 10-Q Molecular Templates, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.30% | |
| Form 8-K Molecular Templates, For: Nov 13 | SEC filing · Form 8-K | +0.00% | +1.30% | |
| Form 8-K Molecular Templates, For: Oct 27 | SEC filing · Form 8-K | +0.00% | -8.17% |
Keep exploring
More MTEM: earnings → · analyst actions → · MTEM overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | 84 | 0.00% | 14% |
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
| PharmaCyte Biotech, Inc. (PMCB) | 84 | 0.00% | 41% |
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.